Management of Chronic Venous Insufficiency

Initial Diagnostic Assessment

• The American College of Phlebology recommends duplex ultrasound as the diagnostic standard for evaluating the deep venous system, documenting presence, absence, and location of reflux (reflux duration ≥500 milliseconds indicates pathologic reflux) 1, 2
• The Society for Vascular Surgery recommends documenting CEAP classification to categorize severity: C0 (no visible signs), C1 (telangiectasias/spider veins), C2 (varicose veins), C3 (edema), C4 (skin changes including pigmentation and lipodermatosclerosis), C5 (healed ulcer), C6 (active ulcer) 1
• Assess specific symptoms including pain, burning, itching, heaviness, cramping, throbbing, and swelling that typically worsen at day's end or after prolonged standing, as recommended by the American Venous Forum 1

Conservative Management

• The American College of Cardiology recommends graduated compression stockings as mandatory initial treatment: 20-30 mmHg for CEAP C1-C3 disease, 30-40 mmHg for C4-C6 disease, worn daily for minimum 3 months before interventional therapy is considered 1
• Compression should be continued for 2 years post-intervention, and beyond if post-thrombotic syndrome develops and patients find stockings helpful, as recommended by the American College of Chest Physicians 3
• Elevate legs above heart level regularly throughout the day to reduce venous hypertension, as recommended by the Society for Vascular Surgery 1
• Avoid prolonged standing or sitting (>30 minutes without movement) to prevent venous pooling, as recommended by the American Venous Forum 1
• Regular calf muscle pump exercises (ankle flexion/extension, walking) to improve venous return, as recommended by the American College of Sports Medicine 1
• Weight loss if BMI >25 to reduce intra-abdominal pressure and venous hypertension, as recommended by the American Heart Association 1
• Avoid restrictive clothing around waist, groin, or legs that impedes venous return, as recommended by the American College of Phlebology 1

Interventional Treatment Algorithm

• Radiofrequency or laser ablation is the primary interventional treatment for saphenous vein reflux when vein diameter ≥4.5mm and reflux duration ≥500ms at saphenofemoral or saphenopopliteal junction, as recommended by the Society for Vascular Surgery 1, 2, 4
• Technical success rates are 91-100% at 1-year follow-up, superior to all other modalities, as reported by the American College of Phlebology 1, 2
• Thermal ablation has replaced surgery as standard of care due to equivalent efficacy with fewer complications, faster recovery, and improved early quality of life, as recommended by the American Venous Forum 1, 2
• Nerve damage occurs in approximately 7% of cases (usually temporary) from thermal injury, as reported by the Society for Vascular Surgery 1, 2
• Deep vein thrombosis occurs in 0.3% and pulmonary embolism in 0.1% of cases, as reported by the American College of Chest Physicians 2
• Foam sclerotherapy (polidocanol/Varithena) is appropriate for tributary veins ≥2.5mm diameter after treating main saphenous trunk reflux, as recommended by the American College of Phlebology 1, 4
• Occlusion rates are 72-89% at 1 year, significantly lower than thermal ablation, as reported by the Society for Vascular Surgery 1, 4
• Sclerotherapy alone has inferior long-term outcomes with higher recurrent reflux rates at 1, 5, and 8-year follow-ups compared to thermal ablation, as reported by the American Venous Forum 1, 4

Critical Treatment Pitfalls to Avoid

• Never perform sclerotherapy alone for saphenofemoral junction reflux without addressing the junction with thermal ablation or ligation, as recommended by the Society for Vascular Surgery 1, 4
• Do not treat veins <2.5mm diameter with sclerotherapy—patency rates are only 16% at 3 months versus 76% for veins >2.5mm, as reported by the American College of Phlebology 4
• Avoid delaying intervention in C4-C6 disease for prolonged compression trials—early thermal ablation prevents progression, as recommended by the American Venous Forum 1, 4
• Ensure ultrasound documentation is <6 months old before any interventional procedure to confirm current anatomy and reflux patterns, as recommended by the Society for Vascular Surgery 4
• Refer to experienced vascular specialists when local expertise is unavailable—outcomes are highly operator-dependent, as recommended by the American College of Phlebology 1

Special Considerations

• Recurrence rates are 20-28% at 5 years even with appropriate treatment, necessitating long-term surveillance, as reported by the American Venous Forum 4
• Post-procedure compression is mandatory to optimize outcomes and reduce complications, as recommended by the Society for Vascular Surgery 2
• Patient selection must account for surgical risk, clinical severity, specific venous anatomy, and life expectancy, as recommended by the American College of Phlebology 1

Evidence‑Based Recommendations for Peripheral Venous Insufficiency Management

Diagnostic Workup

• Duplex ultrasound is the diagnostic standard for documenting the presence, location, and duration of venous reflux (pathologic reflux ≥ 500 ms), assessing deep‑vein patency, measuring saphenous‑vein diameter, and locating perforating veins. American College of Radiology recommendation. 5
• Ankle‑brachial index (ABI) must be measured before compression therapy; compression is contraindicated when ABI < 0.5, and about 16 % of patients with venous insufficiency have concurrent arterial disease. American College of Radiology recommendation. 5

First‑Line Conservative Therapy

• Medical‑grade graduated compression stockings should be prescribed: 20–30 mmHg for CEAP C1–C3 disease and 30–40 mmHg for CEAP C4–C6 disease, worn daily from toes to knee. American College of Radiology recommendation. 5
• Negative‑gradient graduated compression (higher pressure at the calf than the ankle) over the calf region provides superior venous ejection fraction and higher extrinsic pressures compared with traditional graduated compression. American College of Radiology recommendation. 5

Long‑Term Surveillance & Recurrence Management

• If a venous ulcer recurs, repeat duplex ultrasound to evaluate for recanalization of previously treated veins or new reflux pathways (e.g., Giacomini‑vein transmission to the short saphenous vein). American College of Radiology recommendation. 5
• Patient adherence to compression therapy is the most critical factor for preventing ulcer recurrence; proper fitting, education, and detailed instructions are essential. American College of Radiology recommendation. 5

Evidence for Compression Therapy in Varicose Veins without Ulceration

Guideline Recommendations

• The 2013 National Institute for Health and Care Excellence (NICE) guidelines indicate that evidence is insufficient to demonstrate the effectiveness of compression therapy for varicose veins lacking an active or healed ulcer, reflecting a low‑strength recommendation; this position conflicts with American guidelines that mandate compression as mandatory first‑line therapy for chronic venous insufficiency. 6

Evidence‑Based Adjunctive Therapies for Chronic Venous Insufficiency

Pharmacologic Adjuncts

• Adding pentoxifylline 400 mg three times daily to compression therapy increases the relative risk of venous ulcer healing by 1.56 compared with compression alone, although gastrointestinal adverse effects (e.g., nausea, indigestion, diarrhea) occur more frequently. 7

Venous Ulcer Management

• Compression therapy is the cornerstone of venous ulcer treatment; ulcers close more rapidly when compression is applied than when only primary dressings, non‑compressive bandages, or usual care without compression are used. 7
• Maintaining a moist wound environment with an appropriate protective covering optimizes the healing process of venous ulcers. 7
• Effective control of periwound dermatitis and proactive prevention and treatment of infection are essential components of ulcer care. 7

Exercise Training Component

• A supervised exercise program of at least six months that combines leg‑strength training with aerobic activity improves calf‑muscle pump function and may accelerate healing of venous ulcers. 7
• Exercise does not exacerbate leg symptoms after deep‑vein thrombosis nor increase the risk of post‑thrombotic syndrome; many patients experience symptomatic improvement with regular physical activity. 7

Adverse Effects and Tolerability of Diosmin and MPFF

Common Gastrointestinal and Autonomic Adverse Events

Other Mild Side Effects (Related Venoactive Agents)

Evidence‑Based Management of Xerosis and Skin Changes in Chronic Venous Insufficiency

First‑Line Conservative Management

Compression Therapy (mandatory)

• The American College of Radiology recommends applying medical‑grade graduated compression stockings that deliver 20–30 mmHg for patients with CEAP C4 disease (skin xerosis, redness, pigmentation) to reduce venous hypertension and improve skin integrity. 10
• For more severe skin changes or overt stasis dermatitis, the guideline advises escalating compression to 30–40 mmHg to achieve greater venous outflow. 10
• A negative‑gradient design (higher pressure at the calf than the ankle) provides a superior venous ejection fraction and should be preferred over traditional uniform graduated compression. 10
• Therapeutic benefit requires a minimum pressure of 20 mmHg; lower pressures are ineffective. 10
• Compression garments must be worn daily from the toes to the knee to maintain continuous reduction of venous hypertension. 10

Skin Barrier Restoration (adjunct)

• The guideline advises applying ceramide‑containing moisturizers twice daily to restore the impaired skin barrier caused by chronic venous hypertension and inflammation. 10
• Use of gentle, pH‑balanced cleansers is recommended instead of harsh soaps, which can further disrupt the compromised barrier. 10

Lifestyle Modifications (supportive)

• Patients should elevate the legs above heart level regularly throughout the day to lower venous pressure and edema. 10
• Avoidance of prolonged standing or sitting (>30 minutes without movement) is advised to prevent venous pooling. 10
• Calf‑muscle pump exercises (ankle flexion/extension, walking) should be performed regularly to enhance venous return. 10
• For individuals with BMI > 25, weight‑loss counseling is recommended to reduce intra‑abdominal pressure and venous hypertension. 10

Diagnostic Evaluation Prior to Interventions

• Obtain a duplex ultrasound to document reflux duration (≥ 500 ms indicates pathologic reflux), vein diameter, junction competence, and deep‑vein patency before any endovenous procedure. 10
• Measure the ankle‑brachial index (ABI) before applying compression; compression is contraindicated when ABI < 0.5, and about 16 % of patients with venous insufficiency have concurrent arterial disease. 10

Indications for Endovenous Thermal Ablation

• Documented reflux ≥ 500 ms at the saphenofemoral or saphenopopliteal junction on duplex ultrasound performed within the past 6 months. 10
• Vein diameter ≥ 4.5 mm at the junction on ultrasound imaging. 10
• Persistent skin changes or symptoms despite a 3‑month trial of compression therapy; early intervention is encouraged to prevent progression of CEAP C4‑C6 disease. 10
• Confirmation that the deep venous system is patent (no thrombosis) before proceeding. 10

Expected Outcomes of Endovenous and Adjunctive Therapies

• Endovenous thermal ablation (radiofrequency or laser) achieves 91–100 % occlusion rates at 1 year, offering efficacy comparable to surgery with fewer complications. 10
• Foam sclerotherapy for tributary veins yields 72–89 % occlusion rates at 1 year and is appropriate as an adjunct after treating the main saphenous trunk reflux. 10
• Recurrence rates of 20–28 % at 5 years are observed even with optimal treatment, underscoring the need for long‑term surveillance and continued compression. 10

Critical Treatment Pitfalls

• Initiation of compression therapy must not be delayed while awaiting specialist referral; it is the mandatory first‑line intervention. 10
• Treating tributary veins with sclerotherapy alone without addressing saphenofemoral junction reflux leads to persistent downstream pressure and the same 20–28 % 5‑year recurrence rate. 10
• Veins < 2.5 mm in diameter should not be treated with sclerotherapy, as patency rates are only 16 % at 3 months versus 76 % for veins ≥ 2.5 mm. 10
• Patient adherence to compression is the most critical factor for preventing disease progression and recurrence; proper fitting, education, and detailed instructions are essential. 10

Long‑Term Management

• The American College of Radiology recommends indefinite continuation of compression therapy because chronic venous insufficiency is a lifelong condition. 10
• If skin changes worsen or ulceration appears, repeat duplex ultrasound should be performed to assess for recanalization of previously treated veins or new reflux pathways. 10